Close the combination of BD's Biosciences & Diagnostic Solutions business with Waters

Delivered by the deadline

AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.

Announced: 14 Jul 2025
Due: 31 Mar 2026
Delivered: 9 Feb 2026

Deadline
Met
Late
Not met
Today

What the company said

“expected to close around the end of the first quarter of calendar year 2026, subject to receipt of required regulatory approvals”

SourceWaters Corporation Form 8-K press release, 2025-07-14
FilingSEC filing index
Deadline as statedaround the end of the first quarter of calendar year 2026
Deadline used31 Mar 2026, the last day of the stated period
TypeTransaction
Permanent referenceKI-C-2025-WAT-006579
Cite as https://keptindex.org/c/KI-C-2025-WAT-006579/ — this address never changes.

What we found

Evidence strength A What the grades mean

The 10-K filed 2026-02-23 reports that the BDS business acquisition closed on February 9, 2026, ahead of the end-of-Q1 2026 deadline.

A
Waters Corporation 10-K filed 2026-02-23 Regulatory filing · published 23 Feb 2026 · retrieved 11 Oct 2026 · kept permanently by the SEC · fingerprint f29151134e99
“On February 9, 2026, the Company completed the acquisition (the “BDS Business Acquisition”) of the Biosciences and Diagnostic Solutions businesses (the “BDS Business”) of Becton, Dickinson and Company (“BD”)” ✓ confirmed on the page
A
Waters Corporation 8-K filed 2026-05-05 Regulatory filing · published 5 May 2026 · retrieved 11 Oct 2026 · kept permanently by the SEC · fingerprint 19e61156b5c6
“which was acquired by Waters on February 9, 2026” ✓ confirmed on the page

Market reaction: the shares moved -4.7% against the S&P 500 over the three sessions around the disclosure (20 Feb 2026 to 25 Feb 2026). What this measures

Checked 11 Oct 2026.

Commitment lineage

Every time the company restated this commitment. The original is never changed, and the outcome is always measured against version 1.

Deadline drift -50 days
2 versions

Version 1 · original · stated 14 Jul 2025

Deadline 31 Mar 2026 (“around the end of the first quarter of calendar year 2026”) · wording expected
Version 2 · stated 27 Jan 2026

Deadline 9 Feb 2026 (“on February 9, 2026”) · wording expected

“The transaction is expected to close on February 9, 2026, subject to the satisfaction of the remaining customary closing conditions.”
Source for this version

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type: Transaction other
Indicative materiality: Medium rules
Action: Close
Deliverable: Combination of BD Biosciences & Diagnostic Solutions with Waters
Language: Expected (“expects”, “plans”)
In the company’s control: Medium
Specificity: Medium
Conditional: Yes: subject to receipt of required regulatory approvals; Waters shareholder approval; satisfaction of other customary closing conditions
Depends on: Regulatory, Shareholder, Counterparty

How this entry was checked

Commitment recordedThe company's words were matched word for word against the filing.
First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
Second check: agreesA different AI model, Gemini (Google), re-read the evidence without being told the outcome and reached the same answer.

Confirmed. This outcome counts towards the company's Kept Score. How verification works

Are you Waters Corporation? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.